Loop Diuretics Are the Appropriate Choice for GFR 37
For a patient with an eGFR of 37 mL/min/1.73 m², loop diuretics (furosemide, bumetanide, or torsemide) are the recommended diuretic class, as thiazide diuretics are generally ineffective at this level of kidney function.
Why Loop Diuretics at This GFR Level
At an eGFR of 37 mL/min/1.73 m² (CKD stage G3b), you are dealing with moderate-to-severe chronic kidney disease where thiazide diuretics lose their efficacy. Multiple guidelines consistently state that thiazides should not be used when eGFR is <30 mL/min/1.73 m² 1, 2, 3. While your patient's GFR of 37 is technically above this threshold, the proximity to 30 and the reduced nephron mass make loop diuretics the more reliable choice 4, 5, 6, 7.
Loop diuretics work at the loop of Henle and maintain efficacy even with significantly reduced kidney function, whereas thiazides act on the distal tubule and require adequate GFR to reach their site of action in sufficient concentrations 4.
Specific Loop Diuretic Dosing Options
Start with standard doses and titrate based on response 4, 2:
- Furosemide: 20-40 mg once or twice daily initially, can increase to 40-240 mg daily
- Bumetanide: 0.5-1.0 mg once or twice daily initially, can increase to 1-5 mg daily
- Torsemide: 5-10 mg once daily initially, can increase to 10-20 mg daily
Torsemide has the advantage of longer duration of action (12-16 hours) and more predictable bioavailability compared to furosemide 4.
Important Caveats at This GFR Level
Monitor closely for:
- Worsening renal function: Check creatinine and electrolytes within 1-2 weeks after initiation or dose changes 1
- Electrolyte disturbances: Hypokalemia, hypomagnesemia, and hyponatremia are common 4
- Volume depletion: Excessive diuresis can precipitate acute kidney injury, especially problematic at baseline eGFR 37
Avoid over-diuresis: The goal is euvolemia with the lowest effective dose. Inappropriately high doses increase risk of hypotension and further renal insufficiency 4.
The Thiazide Exception: Combination Therapy Only
The only scenario where thiazides are appropriate at eGFR 37 is when combined synergistically with loop diuretics for resistant fluid retention 1, 2. This sequential nephron blockade approach uses:
- Metolazone 2.5-10 mg once daily PLUS loop diuretic
- OR Hydrochlorothiazide 25-100 mg once or twice daily PLUS loop diuretic 4
This combination should be reserved for refractory cases and requires frequent monitoring of creatinine and electrolytes due to profound diuretic effects 1. Recent evidence suggests this combination can be effective even in advanced CKD (eGFR >30), though benefits diminish when eGFR ≤30 8.
Clinical Context Matters
If this patient has heart failure with fluid retention, loop diuretics are definitively indicated 4, 2. If the indication is hypertension alone without volume overload, recent data suggest thiazides may retain some antihypertensive effect independent of diuresis even at eGFR 37-45 9, but loop diuretics remain preferred at this level of kidney function 5, 6, 7.
Bottom line: Start with a loop diuretic, titrate to effect, and monitor kidney function closely. Reserve thiazide addition only for truly resistant cases requiring combination therapy.